ArticleAnalytical chemistry2024
AI-Assisted Real-Time Immunoassay Improves Clinical Sensitivity and Specificity.
Article in Analytical chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Interferometric scattering microscopy supports real-time mass-resolved label-free single-molecule immunoassay.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Real-time biosensing systems can interrogate the association between the analyte and the biorecognition element across time. Typically, the resulting data are preprocessed to offer valuable bioanalytical information obtained at a single optimal point of such a real-time response; for instance, a diagnosis of certain medical conditions can be established depending on a biomarker (analyte) concentration measured at an optimal time, that is, a threshold. Exploiting this conventional approach, we previously developed a nanophotonic immunoassay for bacterial vaginosis diagnosis exhibiting a clinical sensitivity and specificity of ca. 96.29% (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.